Multivariate Logistic Regressions: Continuity with a Primary Care Provider
| Glycosylated Hemoglobin (≥1) | Glycosylated Hemoglobin (≥2) | Lipid Profile | Eye Examination | |||||
|---|---|---|---|---|---|---|---|---|
| Variable | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) |
| OR = odds ratio; CI = confidence interval. | ||||||||
| * Compares continuity score of 1.00 with continuity score of 0.00. | ||||||||
| † Number of outpatient visits during study year for which diabetes was listed as any of 3 diagnoses. | ||||||||
| ‡ Reference group is endocrinologist. | ||||||||
| § Reference group is 55-64 years. | ||||||||
| # Reference group is male. | ||||||||
| ¶ For each diabetic complication, comparison is presence vs absence of complication. | ||||||||
| # Reference group is nonmetropolitan. | ||||||||
| ** For each ambulatory diagnostic group (ADG), comparison is presence vs absence of ADG; only ADGs significant at P <.05 for 1 or more outcomes are included in this table. | ||||||||
| Continuity* | 0.73 | 0.41-1.33 | 1.14 | 0.70-1.86 | 0.88 | 0.53-1.47 | 0.70 | 0.35-1.36 |
| Visits for diabetes, No.† | 1.19 | 1.11-1.27 | 1.20 | 1.14-1.26 | 1.03 | 0.99-1.08 | 1.10 | 1.04-1.16 |
| Specialty‡ | ||||||||
| Generalist | 0.55 | 0.20-1.52 | 0.43 | 0.22-0.84 | 1.20 | 0.67-2.17 | 0.66 | 0.32-1.36 |
| Mixed | 0.40 | 0.14-1.16 | 0.33 | 0.16-0.69 | 0.78 | 0.40-1.52 | 0.41 | 0.18-0.95 |
| Other | 0.45 | 0.15-1.36 | 0.29 | 0.13-0.63 | 1.41 | 0.69-2.88 | 0.57 | 0.24-1.30 |
| Age, years§ | ||||||||
| 18 - 34 | 1.41 | 0.62-3.24 | 0.80 | 0.43-1.50 | 0.35 | 0.19-0.64 | 1.10 | 0.50-2.44 |
| 35 - 44 | 0.93 | 0.60-1.43 | 0.94 | 0.66-1.33 | 0.78 | 0.54-1.11 | 0.94 | 0.59-1.51 |
| 45 - 54 | 0.97 | 0.74-1.28 | 0.85 | 0.68-1.06 | 0.81 | 0.64-1.02 | 0.81 | 0.59-1.09 |
| Sex|| | 0.90 | 0.68-1.19 | 0.86 | 0.69-1.08 | 0.66 | 0.52-0.83 | 0.95 | 0.71-1.27 |
| Diabetes complications¶ | ||||||||
| Renal | 0.61 | 0.28-1.30 | 0.69 | 0.36-1.31 | 0.81 | 0.43-1.52 | 1.79 | 0.82-3.91 |
| Retinal | 1.12 | 0.73-1.74 | 0.93 | 0.67-1.29 | 1.01 | 0.71-1.44 | 3.78 | 2.56-5.58 |
| Neurologic | 1.03 | 0.60-1.76 | 0.97 | 0.64-1.45 | 0.79 | 0.52-1.19 | 0.77 | 0.46-1.28 |
| Peripheral vascular | 1.03 | 0.49-2.17 | 0.65 | 0.36-1.16 | 0.85 | 0.47-1.54 | 0.73 | 0.35-1.53 |
| Residence# | 1.34 | 0.96-1.88 | 1.17 | 0.88-1.56 | 1.95 | 1.47-2.60 | 1.16 | 0.78-1.73 |
| Ambulatory diagnostic groups** | ||||||||
| Time limited: major | 0.56 | 0.39-0.79 | 0.70 | 0.51-0.95 | 0.75 | 0.55-1.02 | 0.91 | 0.61-1.38 |
| Likely to recur: discrete | 0.86 | 0.63-1.16 | 0.72 | 0.57-0.92 | 0.99 | 0.77-1.28 | 0.75 | 0.54-1.04 |
| Chronic medical: stable | 3.45 | 1.73-6.88 | 3.37 | 1.63-6.98 | 4.07 | 2.05-8.06 | 1.50 | 0.59-3.79 |
| Chronic medical: unstable | 1.14 | 0.85-1.51 | 1.32 | 1.05-1.66 | 1.39 | 1.09-1.77 | 1.29 | 0.93-1.78 |
| Chronic specialty: stable—eye | 1.37 | 0.90-2.08 | 1.09 | 0.80-1.48 | 1.08 | 0.79-1.49 | 10.23 | 7.09-14.77 |
| Chronic specialty: unstable—eye | 0.83 | 0.60-1.17 | 0.96 | 0.73-1.26 | 1.00 | 0.75-1.33 | 7.40 | 5.41-10.13 |
| Prevention/administrative | 1.75 | 1.34-2.29 | 1.64 | 1.32-2.05 | 1.59 | 1.27-2.00 | 1.11 | 0.83-1.49 |
| Malignancy | 0.93 | 0.56-1.53 | 0.91 | 0.61-1.35 | 0.57 | 0.38-0.85 | 1.49 | 0.89-2.51 |